Bone mineral density measurements have been criticized on the grounds
that they are not a worth-while screening tool. In this paper we argue
that bone mineral measurements can be an efficient diagnostic tool ev
en if they are not of proven value for screening. There is complex rel
ationship between the costs of a measurement, the intervention and the
predictive value of the test all of which must be accounted for when
assessing the value of a bone density measurement. For bone density me
asurements to be used for screening, a wider evaluation needs to be un
dertaken compared with that for their use as a diagnostic tool. We add
ress some common objections, for example, that low compliance with scr
eening would undermine efficiency, and show that these are not relevan
t. Evaluations of screening need to address issues that are likely to
affect efficiency.